Molecular and Cellular Biology · 2008 · 61 citations · 61 references
Life SciencesCell BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingMammary Epithelial Cell BiologyOncogenic Signaling PathwaysReceptor Tyrosine Kinase SignalingSignal Transduction In CancerSteroid Hormone SignalingCancer Signaling PathwaysEstrogen Receptor SignalingInsulin-like Growth Factor-1Protein Tyrosine PhosphorylationReceptor Tyrosine Kinase ActivationSteroid Receptor CoactivatorsTyrosine Phosphorylation Signaling
Overexpression and activation of the steroid receptor coactivator amplified in breast cancer 1 (AIB1)/steroid receptor coactivator-3 (SRC-3) have been shown to have a critical role in oncogenesis and are required for both steroid and growth factor signaling in epithelial tumors. Here, we report a new mechanism for activation of SRC coactivators. We demonstrate regulated tyrosine phosphorylation of AIB1/SRC-3 at a C-terminal tyrosine residue (Y1357) that is phosphorylated after insulin-like growth factor 1, epidermal growth factor, or estrogen treatment of breast cancer cells. Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters. c-Abl (v-Abl Abelson murine leukemia viral oncogene homolog 1) tyrosine kinase directly phosphorylates AIB1/SRC-3 at Y1357 and modulates the association of AIB1 with c-Abl, ERalpha, the transcriptional cofactor p300, and the methyltransferase coactivator-associated arginine methyltransferase 1, CARM1. AIB1/SRC-3-dependent transcription and phenotypic changes, such as cell growth and focus formation, can be reversed by an Abl kinase inhibitor, imatinib. Thus, the phosphorylation state of Y1357 can function as a molecular on/off switch and facilitates the cross talk between hormone, growth factor, and intracellular kinase signaling pathways in cancer.
61
Basic local alignment search tool
Stephen F. Altschul, Warren Gish, Webb Miller et al. · Journal of Molecular Biology · 1990 · 94.5K citations
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Thomas H. Schindler, William G. Bornmann, Patricia Pellicena et al. · Science · 2000 · 1.8K citations
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Sarah L. Anzick, Juha Kononen, Robert L. Walker et al. · Science · 1997 · 1.7K citations